Cargando…
Sorafenib-induced Prostate Volume Reduction, a New Adverse Effect Detected by Imaging: A Pilot Study
BACKGROUND: Sorafenib has been used in the treatment of advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Sorafenib-associated organ reduction have been reported on imaging, such as thyroid, pancreas and muscle, but there has been no research on prostate volume reduction (PVR)....
Autores principales: | Takahashi, Hiroaki, Masuoka, Sota, Nasu, Katsuhiro, Mori, Kensaku, Kojima, Takahiro, Fukuda, Kuniaki, Takahashi, Kazuhiro, Ishiguro, Toshitaka, Hosokawa, Takahiro, Minami, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208293/ https://www.ncbi.nlm.nih.gov/pubmed/30386849 http://dx.doi.org/10.5334/jbsr.1607 |
Ejemplares similares
-
Organ Atrophy Induced by Sorafenib and Sunitinib – Quantitative Computed Tomography (CT) Evaluation of the Pancreas, Thyroid Gland and Spleen
por: Takahashi, Hiroaki, et al.
Publicado: (2016) -
Thoracic abnormal air collections in patients in the intensive care unit: radiograph findings correlated with CT
por: Sakai, Masafumi, et al.
Publicado: (2020) -
Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy
por: Takahashi, Hiroaki, et al.
Publicado: (2019) -
Predisposing conditions for bacterial meningitis in children: what radiologists need to know
por: Masuoka, Sota, et al.
Publicado: (2021) -
Diagnosing Ovarian Cancer on MRI: A Preliminary Study Comparing Deep Learning and Radiologist Assessments
por: Saida, Tsukasa, et al.
Publicado: (2022)